FDA
-
-
-
-
-
-
-
Daxor launches blood volume testing program at Ohio cardiology center
-
-
-
-
-
-
-
Daxor reports 45% revenue growth, plans regulatory shift to Exchange Act
-
-
-
-
-
-
-
Daxor Fuels Growth with Three New Facility Adoptions and Deployment of Next-Generation BVA Analyzer
-
-
-
-
-
-
-
Daxor's Blood Volume Analysis Validated for COVID and Sepsis Patients in New Peer-Reviewed Pilot Study Published in the Journal of Critical Care
-
-
-
-
-
-
-
Daxor’s Blood Volume Analysis Technology Accelerates Market Penetration with Three New Facility Adoptions
-
-
-
-
-
-
-
Daxor Corporation to Exhibit at the 45th International Society for Heart and Lung Transplant (ISHLT) Annual Meeting and Scientific Sessions
-
-
-
-
-
-
-
Daxor Expands Blood Volume Analysis Technology Across Midwest, Wisconsin, and New Jersey Healthcare Networks
-
328,024 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

